M- PIMA HIV Viral load

Designed to provide actionable results while the patient is still present.

WHO recommends a viral load test at 6 months and 12 months, and annually thereafter if the patient is stable on ART1, but few patients receive that level of care.

UNAIDS 909090 Goal: 90% of patients on ART virally suppressed by 2020, but only 44% actually are.2
Approximately 50% of the viral load testing need in low to middle income countries is unmet.2
By 2021 low to middle income countries will need an estimated 30 million viral load tests.3

The m-PIMA™ HIV-1/2 VL test is now commercially available in select countries, and has received CE-IVD marking and WHO prequalification. This product is not available in the United States.